The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Mar. 14, 2019
Applicant:

Enlitic, Inc., San Francisco, CA (US);

Inventors:

Kevin Lyman, Fords, NJ (US);

Anthony Upton, Malvern, AU;

Ben Covington, Berkeley, CA (US);

Li Yao, San Francisco, CA (US);

Keith Lui, San Francisco, CA (US);

Assignee:

Enlitic, Inc., San Francisco, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G16H 10/60 (2018.01); H04L 67/01 (2022.01); G16H 30/40 (2018.01); G16H 15/00 (2018.01); G06K 9/62 (2022.01); G06T 5/00 (2006.01); G06T 5/50 (2006.01); G06T 7/00 (2017.01); G06T 11/00 (2006.01); G06N 5/04 (2006.01); G16H 30/20 (2018.01); G06N 20/00 (2019.01); G06F 9/54 (2006.01); G06T 7/187 (2017.01); G06T 7/11 (2017.01); G06F 3/0482 (2013.01); G06T 3/40 (2006.01); A61B 5/00 (2006.01); G16H 50/20 (2018.01); G06F 21/62 (2013.01); G06V 10/22 (2022.01); G06V 30/194 (2022.01); G06Q 20/14 (2012.01); G16H 40/20 (2018.01); G06F 3/0484 (2022.01); G06Q 10/06 (2012.01); G16H 10/20 (2018.01); G06T 7/10 (2017.01); G06T 11/20 (2006.01); G06F 16/245 (2019.01); G06T 7/44 (2017.01); G06N 20/20 (2019.01); H04L 67/12 (2022.01); G16H 50/70 (2018.01); G06T 7/70 (2017.01); G16H 50/30 (2018.01); A61B 5/055 (2006.01); A61B 6/03 (2006.01); A61B 8/00 (2006.01); A61B 6/00 (2006.01); G06Q 50/22 (2018.01); G06F 40/295 (2020.01);
U.S. Cl.
CPC ...
G16H 10/60 (2018.01); A61B 5/7264 (2013.01); G06F 3/0482 (2013.01); G06F 3/0484 (2013.01); G06F 9/542 (2013.01); G06F 16/245 (2019.01); G06F 21/6254 (2013.01); G06K 9/6231 (2013.01); G06K 9/6254 (2013.01); G06K 9/6256 (2013.01); G06K 9/6262 (2013.01); G06K 9/6277 (2013.01); G06N 5/04 (2013.01); G06N 5/045 (2013.01); G06N 20/00 (2019.01); G06N 20/20 (2019.01); G06Q 10/06315 (2013.01); G06Q 20/14 (2013.01); G06T 3/40 (2013.01); G06T 5/002 (2013.01); G06T 5/008 (2013.01); G06T 5/50 (2013.01); G06T 7/0012 (2013.01); G06T 7/0014 (2013.01); G06T 7/10 (2017.01); G06T 7/11 (2017.01); G06T 7/187 (2017.01); G06T 7/44 (2017.01); G06T 7/97 (2017.01); G06T 11/001 (2013.01); G06T 11/006 (2013.01); G06T 11/206 (2013.01); G06V 10/225 (2022.01); G16H 10/20 (2018.01); G16H 15/00 (2018.01); G16H 30/20 (2018.01); G16H 30/40 (2018.01); G16H 40/20 (2018.01); G16H 50/20 (2018.01); H04L 67/12 (2013.01); H04L 67/42 (2013.01); A61B 5/055 (2013.01); A61B 6/032 (2013.01); A61B 6/5217 (2013.01); A61B 8/4416 (2013.01); G06F 40/295 (2020.01); G06K 9/6229 (2013.01); G06K 9/6267 (2013.01); G06Q 50/22 (2013.01); G06T 7/70 (2017.01); G06T 2200/24 (2013.01); G06T 2207/10048 (2013.01); G06T 2207/10081 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/10116 (2013.01); G06T 2207/10132 (2013.01); G06T 2207/20076 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01); G06T 2207/30004 (2013.01); G06T 2207/30008 (2013.01); G06T 2207/30016 (2013.01); G06T 2207/30061 (2013.01); G06V 30/194 (2022.01); G06V 2201/03 (2022.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01);
Abstract

A lesion tracking system is operable to receive a first medical scan and second medical scan associated with a patient ID. A lesion area calculation is performed on a first subset of image slices determined to include a lesion detected in the first medical to generate a first set of lesion area measurements. The lesion area calculation is performed on a second subset of image slices determined to include the lesion in the second medical scan to generate a second set of lesion area measurements. A lesion volume calculation is performed on the first set of lesion area measurements and the second set of lesion area measurements to generate a first lesion volume measurement and a second lesion volume measurement, respectively, and the first and second lesion volume measurements are utilized to calculate a lesion volume change for transmission to a client device for display via a display device.


Find Patent Forward Citations

Loading…